The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Subcutaneous trastuzumab therapy for HER2-positive early breast cancer in the routine clinical practice: First interim analysis of the National Non-Interventional Study (NIS) HerSCin.
 
Marcus Schmidt
Honoraria - AstraZeneca; Celgene; Pfizer; Roche; Sividon Diagnostics
Consulting or Advisory Role - AstraZeneca; Celgene; Pfizer; Roche; Sividon Diagnostics
Speakers' Bureau - Celgene; Pfizer; Roche; Sividon Diagnostics
Research Funding - Pierre Fabre
Patents, Royalties, Other Intellectual Property - Sividon Diagnostics
Travel, Accommodations, Expenses - Amgen; Pierre Fabre; Roche
 
Sherko Kummel
Honoraria - Amgen; Celgene; Genomic Health; Novartis; Roche
Consulting or Advisory Role - Roche
Research Funding - Roche
Travel, Accommodations, Expenses - Celgene; Roche
 
Antonia Ruf-Doerdelmann
Consulting or Advisory Role - Roche
 
Andrea Distelrath
No Relationships to Disclose
 
Juergen Wacker
No Relationships to Disclose
 
Sabine Schmatloch
No Relationships to Disclose
 
Stella Keitel
Employment - Roche
 
Kerstin Luedtke-Heckenkamp
Travel, Accommodations, Expenses - AstraZeneca; Merck; Pfizer